# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007438
Filing Date
2022-05-05
Accepted
2022-05-05 16:50:45
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ptgx-20220331x10q.htm iXBRL | 10-Q | 1596856
2 | EX-10.1 | ptgx-20220331xex10d1.htm | EX-10.1 | 36215
3 | EX-31.1 | ptgx-20220331xex31d1.htm | EX-31.1 | 10119
4 | EX-31.2 | ptgx-20220331xex31d2.htm | EX-31.2 | 10143
5 | EX-32.1 | ptgx-20220331xex32d1.htm | EX-32.1 | 9500
6 | GRAPHIC | ptgx-20220331x10q007.jpg | GRAPHIC | 91932
7 | GRAPHIC | ptgx-20220331xex10d1001.jpg | GRAPHIC | 18721
| Complete submission text file | 0001558370-22-007438.txt |  | 7286822

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | EX-101.SCH | ptgx-20220331.xsd | EX-101.SCH | 53708
9 | EX-101.CAL | ptgx-20220331_cal.xml | EX-101.CAL | 47924
10 | EX-101.DEF | ptgx-20220331_def.xml | EX-101.DEF | 228038
11 | EX-101.LAB | ptgx-20220331_lab.xml | EX-101.LAB | 413995
12 | EX-101.PRE | ptgx-20220331_pre.xml | EX-101.PRE | 352773
63 | EXTRACTED XBRL INSTANCE DOCUMENT | ptgx-20220331x10q_htm.xml | XML | 1278701

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 22897288
SIC: 2834 Pharmaceutical Preparations